Trials Sponsors Conditions Drugs Pricing

Conditions

Atrial Fibrillation

Keywords

Atrial FibrillationAF

Outcome Measures

Primary Outcomes (1)

Evaluation of the management of patients with Atrial Fibrillation.
Evaluation of the use of anticoagulants and antithrombotic drugs. Evaluation of the doctors' compliance with the guidelines.
1 year

Secondary Outcomes (5)

Evaluation of the risk of strokes.
Baseline-6month-12months
Assessment of morbidity and mortality of patients with AF.
1 year
Assessment of the compliance of patients to treatment.
Baseline-6months-12months
Assessment of the awareness of patients about the Atrial Fibrillation.
Baseline
Assessment of patients' quality of life.
Baseline-6months-12months

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

The MANAGE-AF study will enroll 600 consecutive patients from the emergency cardiology departments and outpatient clinics in about 35 Greek hospitals. Their selection will be made in an effort to recruit a representative sample of patients from different geographic areas and stratums of the country.

You may qualify if:

Patients aged ≥ 18 years with any type of AF(first diagnosed, paroxysmal, persistent, long-standing persistent and permanent) according to the classification described in the recent ESC guidelines.

Sponsors & Collaborators

Hellenic Cardiovascular Research Society
Otherlead
Bayer
Industrycollaborator

Study Sites (27)

University Hospital of Alexandroupoli

Alexandroupoli, Greece

7th IKA Hospital of Athens

Athens, Greece

Alexandra Hospital

Athens, Greece

Euroclinic Athens

Athens, Greece

General Hospital of Athens Evangelismos

Athens, Greece

Henry Dunant Hospital

Athens, Greece

KAT General Hospital

Athens, Greece

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Panos E. Vardas, MD, FESC, FACC
President, Hellenic Cardiovascular Research Society
PRINCIPAL INVESTIGATOR

Enrollment

603 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 16, 2011

First Posted

March 17, 2011

Study Start

March 2011

Date type not reported

This date has not been verified as actual or estimated.

Current Clinical Practice in the Management of Atrial Fibrillation in Greece: the MANAGE-AF Study

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (5)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (27)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (5)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (27)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations